These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 15930090

  • 1. Low rates of testing and diagnostic codes usage in a commercial clinical laboratory: evidence for lack of physician awareness of chronic kidney disease.
    Stevens LA, Fares G, Fleming J, Martin D, Murthy K, Qiu J, Stark PC, Uhlig K, Van Lente F, Levey AS.
    J Am Soc Nephrol; 2005 Aug; 16(8):2439-48. PubMed ID: 15930090
    [Abstract] [Full Text] [Related]

  • 2. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
    Minutolo R, De Nicola L, Mazzaglia G, Postorino M, Cricelli C, Mantovani LG, Conte G, Cianciaruso B.
    Am J Kidney Dis; 2008 Sep; 52(3):444-53. PubMed ID: 18468747
    [Abstract] [Full Text] [Related]

  • 3. Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective.
    Ravera M, Noberasco G, Re M, Filippi A, Gallina AM, Weiss U, Cannavò R, Ravera G, Cricelli C, Deferrari G.
    Nephrol Dial Transplant; 2009 May; 24(5):1528-33. PubMed ID: 19073656
    [Abstract] [Full Text] [Related]

  • 4. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program.
    Akbari A, Swedko PJ, Clark HD, Hogg W, Lemelin J, Magner P, Moore L, Ooi D.
    Arch Intern Med; 2004 Sep 13; 164(16):1788-92. PubMed ID: 15364673
    [Abstract] [Full Text] [Related]

  • 5. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes.
    Van Biesen W, Vanholder R, Veys N, Verbeke F, Delanghe J, De Bacquer D, Lameire N.
    Nephrol Dial Transplant; 2006 Jan 13; 21(1):77-83. PubMed ID: 16221704
    [Abstract] [Full Text] [Related]

  • 6. Diabetes mellitus and CKD awareness: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES).
    Whaley-Connell A, Sowers JR, McCullough PA, Roberts T, McFarlane SI, Chen SC, Li S, Wang C, Collins AJ, Bakris GL, KEEP Investigators.
    Am J Kidney Dis; 2009 Apr 13; 53(4 Suppl 4):S11-21. PubMed ID: 19285607
    [Abstract] [Full Text] [Related]

  • 7. Chronic kidney disease in hypertension under specialist care: the I-DEMAND study.
    Leoncini G, Viazzi F, Rosei EA, Ambrosioni E, Costa FV, Leonetti G, Pessina AC, Trimarco B, Volpe M, Deferrari G, Pontremoli R.
    J Hypertens; 2010 Jan 13; 28(1):156-62. PubMed ID: 19915481
    [Abstract] [Full Text] [Related]

  • 8. CKD progression and mortality among older patients with diabetes.
    Patel UD, Young EW, Ojo AO, Hayward RA.
    Am J Kidney Dis; 2005 Sep 13; 46(3):406-14. PubMed ID: 16129201
    [Abstract] [Full Text] [Related]

  • 9. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 13; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 10. SCreening for Occult REnal Disease (SCORED): a simple prediction model for chronic kidney disease.
    Bang H, Vupputuri S, Shoham DA, Klemmer PJ, Falk RJ, Mazumdar M, Gipson D, Colindres RE, Kshirsagar AV.
    Arch Intern Med; 2007 Feb 26; 167(4):374-81. PubMed ID: 17325299
    [Abstract] [Full Text] [Related]

  • 11. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R, Cholewa M.
    Pol Merkur Lekarski; 2008 Jun 26; 24(144):487-91. PubMed ID: 18702327
    [Abstract] [Full Text] [Related]

  • 12. Chronic kidney disease, prevalence of premature cardiovascular disease, and relationship to short-term mortality.
    McCullough PA, Li S, Jurkovitz CT, Stevens L, Collins AJ, Chen SC, Norris KC, McFarlane S, Johnson B, Shlipak MG, Obialo CI, Brown WW, Vassalotti J, Whaley-Connell AT, Brenner RM, Bakris GL, KEEP Investigators.
    Am Heart J; 2008 Aug 26; 156(2):277-83. PubMed ID: 18657657
    [Abstract] [Full Text] [Related]

  • 13. Association between the metabolic syndrome and chronic kidney disease in Chinese adults.
    Chen J, Gu D, Chen CS, Wu X, Hamm LL, Muntner P, Batuman V, Lee CH, Whelton PK, He J.
    Nephrol Dial Transplant; 2007 Apr 26; 22(4):1100-6. PubMed ID: 17272313
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular disease in early stages of chronic kidney disease in a Chinese population.
    Zhang L, Zuo L, Wang F, Wang M, Wang S, Lv J, Liu L, Wang H.
    J Am Soc Nephrol; 2006 Sep 26; 17(9):2617-21. PubMed ID: 16885404
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease.
    Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, Foley RN, Chen SC, Arneson TJ.
    Am J Kidney Dis; 2009 Mar 26; 53(3 Suppl 3):S71-7. PubMed ID: 19231764
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).
    Kalaitzidis R, Li S, Wang C, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 26; 53(4 Suppl 4):S22-31. PubMed ID: 19285608
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.